本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Enliven Treateutics

22.45
-0.3300-1.45%
盤後22.450.00000.00%16:10 EDT
成交量:34.35萬
成交額:776.83萬
市值:12.90億
市盈率:-11.62
高:23.21
開:22.53
低:21.99
收:22.78
資料載入中...
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/19

SEC問詢函

Form CORRESP - Correspondence
2024/04/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

重要事件披露

Form 8-K - Current report
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/09

重要事件披露

Form 8-K - Current report
2024/04/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]